WANBURY LTD.
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹59.45
- Today's High:
- ₹61.23
- Open Price:
- ₹59.6
- 52W Low:
- ₹33.3
- 52W High:
- ₹88.55
- Prev. Close:
- ₹62.57
- Volume:
- 18781
Company Statistics
- Market Cap.:
- ₹1.28 billion
- Book Value:
- -9.502
- Revenue TTM:
- ₹5.01 billion
- Operating Margin TTM:
- 2.18%
- Gross Profit TTM:
- ₹2.04 billion
- Profit Margin:
- 14.2%
- Return on Assets TTM:
- 2.38%
- Return on Equity TTM:
- 0%
Company Profile
WANBURY LTD. had its IPO on under the ticker symbol WANBURY.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. WANBURY LTD. has a staff strength of 1,384 employees.
Stock update
Shares of WANBURY LTD. opened at ₹59.6 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹59.45 - ₹61.23, and closed at ₹59.45.
This is a -4.99% slip from the previous day's closing price.
A total volume of 18,781 shares were traded at the close of the day’s session.
In the last one week, shares of WANBURY LTD. have increased by +7.31%.
WANBURY LTD.'s Key Ratios
WANBURY LTD. has a market cap of ₹1.28 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.3148.
In the last 12-months WANBURY LTD.’s revenue was ₹5.01 billion with a gross profit of ₹2.04 billion and an EBITDA of ₹202.78 million. The EBITDA ratio measures WANBURY LTD.'s overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, WANBURY LTD.’s operating margin was 2.18% while its return on assets stood at 2.38% with a return of equity of 0%.
In Q4, WANBURY LTD.’s quarterly earnings growth was a negative -94.9% while revenue growth was a positive 0.8%.
WANBURY LTD.’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 1.7588
- PEG
Its diluted EPS in the last 12-months stands at ₹22.26 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into WANBURY LTD.’s profitability.
WANBURY LTD. stock is trading at a EV to sales ratio of 0.4476 and a EV to EBITDA ratio of 2.1317. Its price to sales ratio in the trailing 12-months stood at 0.3148.
WANBURY LTD. stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹0
- Total Liabilities
- ₹0
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
WANBURY LTD. ended 2024 with ₹0 in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹0 while shareholder equity stood at ₹0.
WANBURY LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹0 in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
WANBURY LTD.’s total current assets stands at ₹0 while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹0 compared to accounts payable of ₹0 and inventory worth ₹0.
In 2024, WANBURY LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, WANBURY LTD. paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹59.45
- 52-Week High
- ₹88.55
- 52-Week Low
- ₹33.3
- Analyst Target Price
- ₹
WANBURY LTD. stock is currently trading at ₹59.45 per share. It touched a 52-week high of ₹88.55 and a 52-week low of ₹88.55. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹53.43 and 200-day moving average was ₹47.23 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 5984% of the company’s stock are held by insiders while 386.8% are held by institutions.
Frequently Asked Questions About WANBURY LTD.
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology, orthopedics, heamatinics, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner purposes approximately under 70 brands. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. Wanbury Limited also exports its products. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.